Dr. Sanket Mehta

MBBS, MS – General Surgery,

Fellowship – Oncology and Cytoreductive Surgery

In his practice, Dr. Sanket Mehta focuses on providing quality surgical treatment
with surgical proficiency. The highest quality services combine complex procedures,
medical expertise, a humane touch, and a vision of excellence.


Speciality Surgical Oncology is Dr. Sanket Mehta’s brainchild. Dr. Sanket Mehta is a well-known name in the country in the field of Cytoreductive Surgery and HIPEC.

Cytoreductive surgery and HIPEC is a surgical procedure performed for advanced ovarian and advanced GI malignancies, peritoneal mesotheliomas, primary peritoneal tumors. Alumni of Tata Memorial Centre and Trained in France, Dr. Sanket has one of the largest numbers of HIPEC surgeries in the country.

He is currently the president of the Society of Peritoneal Surface Oncology of India. His other areas of focus are Image-guided liver surgeries for advanced liver metastasis, retroperitoneal tumors, hepatobiliary surgery.

  • Pioneer of Crs & Hipec
  • 1000+ Surgeries 
  • 12+ Years of Experience

    OPD Locations & Timings

    Address: 2nd Floor, Aman Chambers, Opp Charni Road Station, Next to Saifee Hospital, Mumbai, Maharashtra 400004
    Days: Monday, Wednesday, Friday
    Timing: 05:00 pm – 08:00 pm

    Address: RB Mehta Marg, Pant Nagar, Ghatkopar East, Mumbai, Maharashtra 400077
    Days: Monday, Thursday
    Timing: 11:00 am – 1:00 pm, 6:00 pm – 8:00 pm

    Experience / Education

    • In professional practice since 2011
    • Performed more than 800 cytoreductive surgeries, more than 450 laparoscopic and Robotic cancer surgeries
    • In 2017, co-founded the Society of Peritoneal Surface Oncology, India (SPSOi) and the Indian HIPEC Registry, the first disease specific registry in the country. SPSOi currently has more than 100 members and the Indian HIPEC registry has more than 450 prospectively collected case details with 11 publications to its credit in 2 years of activity.


    • Fellowship in Laparoscopic and Robotic Colo-rectalsurgery department, St. Mary’sHospital, Catholic University of Korea, Seoul, South Korea
    • Fellowship in Gastro-intestinal Oncology and CRS and HIPEC, CRLC Vald’Aurelle, Montpellier, France
    • Clinical Fellow Digestive and Minimal Invasive Surgery, L’Hopital Saint-Eloi, CHU Montpellier, France
    • Fellowship in CRS and HIPEC at Medstar Washington Memorial Hospital with Dr. Paul Sugarbaker


    • Cytoreductive surgery and HIPEC
    • PIPAC
    • Recurrent malignancy in GI and Gynecology
    • Laparoscopic and Robotic Abdominal and Thoracic Surgeries
    • Image-Guided Liver Surgeries, Hepato-Pancreato-Biliary Surgeries
    • Retroperitoneal Tumors


    Research 1:

    Malignant hepatic perivascular epithelioid cell tumor (PEComa) – Case report and a brief review

    Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms which can arise from almost any location in the body.

    Read More

    Research 2:

    Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry

    The Indian HIPEC registry is a self-funded registry instituted by a group of Indian surgeons for patients with peritoneal metastases (PM) undergoing surgical treatment.

    Read More

    Research 3:

    Laparoscopic versus open distal pancreatectomy: a single-institution case-control study

    Laparoscopic distal pancreatic surgery has gained popularity in the last decade. However, well-designed studies comparing laparoscopic distal pancreatectomy (LDP) to open distal pancreatectomy (ODP) are limited.

    Read More

    Educate Patients

    Let’s clear in detail about your problems